Pharmacology
A section of Pharmaceuticals (ISSN 1424-8247).
Section Information
This section essentially covers all aspects of pharmacology, including pharmacodynamics, pharmacokinetics and toxicology. Research papers should provide rigorous quantitative analyses and/or new insights on intermolecular reactions of drugs with chemical constituents of cells, tissues, organs or organ systems.
It publishes high quality original research and authoritative reviews, commentary and letters to the editor. Download Section Flyer
Keywords
- Behavioral pharmacology
- Cancer pharmacology
- Cardiovascular pharmacology
- Chronopharmacology
- Clinical pharmacology
- Immunopharmacology
- Molecular and biochemical pharmacology
- Neuropharmacology
- Pharmacoepidemiology
- Pharmacogenetics/pharmacogenomics
- Pharmacokinetics
- Systems pharmacology
- Toxicology
- Translational pharmacology/medicine
- Safety pharmacology
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2023 (Deadline: 20 December 2024)
- Infectious Disease Epidemiology and Pharmaceutical Development (Deadline: 20 December 2024)
- Wnt Signaling in Cancer: New Advances (Deadline: 20 December 2024)
- Pharmacotherapy for Schizophrenia: New Advances (Deadline: 22 December 2024)
- New Perspectives in Ocular Pharmacology (Deadline: 23 December 2024)
- Targeting Apoptosis as a Strategy for Developing New Drugs (Deadline: 24 December 2024)
- Purinergic Signaling: A New Pharmacological Target (Deadline: 25 December 2024)
- Kynurenine Pathway: A Novel Therapeutic Opportunity (Deadline: 25 December 2024)
- The 20th Anniversary of Pharmaceuticals—Advances in Pharmacology (Deadline: 25 December 2024)
- Recent Advances in Psychopharmacology (Deadline: 25 December 2024)
- 20th Anniversary of Pharmaceuticals—Advances in Pathophysiology, Pharmacology and Neuroprotection in Glaucoma (Deadline: 25 December 2024)
- Recent Advances in Ocular Pharmacology (Deadline: 25 December 2024)
- Calcium Channels as Therapeutic Targets (Deadline: 31 December 2024)
- Biomarkers and Therapeutic Targets for Melanoma (Deadline: 31 December 2024)
- Current Pharmacotherapy for Viral Hepatitis (Deadline: 31 December 2024)
- Therapeutic Potential of Chalcone Derivatives (Deadline: 15 January 2025)
- Biological and Pharmacological Research on Indole-3-Carbinol (I3C) and Its Derivatives (Deadline: 15 January 2025)
- Exploring the Anticancer and Immunomodulatory Mechanisms of Phytochemicals and Natural Bioactive Compounds (Deadline: 15 January 2025)
- Novel Therapeutic Targets and Approaches for the Treatment for Alzheimer's Disease (Deadline: 20 January 2025)
- Pharmacotherapy of Gastric Cancer (Deadline: 20 January 2025)
- Drug Candidates for the Treatment of Atopic Dermatitis (Deadline: 25 January 2025)
- Advances in Neuropharmacology of Drug Abuse (Deadline: 25 January 2025)
- Sirtuins as Novel Biological Targets for Pharmacological Intervention in Physiology and Pathology (Deadline: 25 January 2025)
- Medications: Interactions with Diet, Herbs, Dietary Supplements and Probiotics (Deadline: 25 January 2025)
- Management of Pain in Oral Mucositis (Deadline: 25 January 2025)
- Recent Advances in the Pharmacology of Serotonin and Its Receptors, 2nd Edition (Deadline: 25 January 2025)
- Affective Disorders Psychopharmacology (Deadline: 31 January 2025)
- Development of Antibacterial Drugs to Combat Drug-Resistant Bacteria (Deadline: 31 January 2025)
- Osteosarcomas: Treatment Strategies, 2nd Edition (Deadline: 31 January 2025)
- Molecular Mechanisms and Treatment of Brain Cancer: Recent Advances and Future Trends (Deadline: 31 January 2025)
- Therapeutic Targets and Therapies for the Treatment of Oral Cancer and Oral Diseases (Deadline: 31 January 2025)
- Bone Disorder Therapeutics: Novel Drug Candidates and Treatment Strategies (Deadline: 31 January 2025)
- Recent Advances in Modulating Mitophagy with Novel Drugs/Compounds (Deadline: 5 February 2025)
- New Street Opioids, Their Mixtures and Emerging Interventions (Deadline: 10 February 2025)
- Recent Advances in TGF-β Inhibitors for the Therapeutic Management of Cancer and Fibrosis (Deadline: 20 February 2025)
- Transient Receptor Potential (TRP) Channels as Novel Therapeutic Targets (Deadline: 20 February 2025)
- Targeted Therapies for Epilepsy (Deadline: 20 February 2025)
- Advances in Pharmacotherapy of Neuropathic Pain (Deadline: 20 February 2025)
- Novel Therapeutics in Hematology (Deadline: 20 February 2025)
- Tumor Immunopharmacology (Deadline: 21 February 2025)
- Adjuvant Therapies for Cancer Treatment (Deadline: 24 February 2025)
- Current Therapies for Endometriosis, Adenomyosis and Endometrial Cancer (Deadline: 24 February 2025)
- New Insights into Therapy for Alzheimer’s and Other Neurodegenerative Diseases (Deadline: 24 February 2025)
- Barrier Dynamics and Immune Interplay in Brain Aging and Injury (Deadline: 24 February 2025)
- Data-Driven Biomarker and Drug Discovery for Complex Disease (Deadline: 24 February 2025)
- Optimized or Precise Pharmacological Treatment of Bipolar Disorder (Deadline: 25 February 2025)
- Pharmacotherapy of Thromboembolism (Deadline: 25 February 2025)
- Therapeutic Potential for Cannabinoid and Its Receptor (Deadline: 25 February 2025)
- Gut Microbiota Metabolites in Intestinal Inflammation and Fibrosis (Deadline: 25 February 2025)
- Small Molecules in Targeted Cancer Therapy and Diagnosis (Deadline: 25 February 2025)
- Pharmacotherapy for Retinopathy (Deadline: 25 February 2025)
- New Targets and Experimental Therapeutic Approaches for Cancers (Deadline: 25 February 2025)
- Pharmacological Therapies for Stress-Related Disorders and Autism Spectrum Disorder (Deadline: 25 February 2025)
- Psychiatric Drug Treatment and Drug Addiction (Deadline: 25 February 2025)
- Novel Antimicrobials and the Antimicrobial Activity: New Advances (Deadline: 25 February 2025)
- P2X Receptors and Their Pharmacology (Deadline: 25 February 2025)
- Neuropsychiatric Disorders: Pharmacological Aspects (Deadline: 25 February 2025)
- Potassium Channels as Novel Therapeutic Targets (Deadline: 26 February 2025)
- Drug-Induced and Herbal Hepatotoxicity and Methods of Its Prevention (Deadline: 28 February 2025)
- Therapeutic Potential of Cannabinoid Receptors Type 1 and 2—Novel Insights for Enhancing the Chance of Clinical Success (Deadline: 28 February 2025)
- Pharmacotherapy of Neurodegeneration Disorders (Deadline: 28 February 2025)
- Pharmacotherapy for Macular Diseases 2024 (Deadline: 28 February 2025)
- Drug Resistance Against Cancer Treatment (Deadline: 28 February 2025)
- Lithium in Psychiatric Therapy: Celebrating 75th Anniversary (Deadline: 28 February 2025)
- Recent Advances in Androgen Receptor Modulators (Deadline: 28 February 2025)
- Recent Advances in Drug Metabolism, Transport, and Pharmacokinetics (Deadline: 28 February 2025)
- Novel Therapeutic Approaches for Chronic Urticaria: Advances and Challenges (Deadline: 28 February 2025)
- Multi-target Drug Treatments for Neurodegenerative Disease (Deadline: 10 March 2025)
- Antidepressant Drug (Deadline: 10 March 2025)
- Advances in Cancer Treatment and Toxicity (Deadline: 10 March 2025)
- Novel Therapeutic Approaches for Cystic Fibrosis (Deadline: 20 March 2025)
- Pharmacological Insight into NMDA Receptor Antagonists (Deadline: 25 March 2025)
- Dopamine and Serotonin Receptors: Selective or Multitarget Ligands for the Treatment of Central Nervous System Diseases (Deadline: 25 March 2025)
- Drug Safety and Risk Management in Clinical Practice (Deadline: 25 March 2025)
- Pharmacotherapy of Liver Fibrosis and Hepatitis: Recent Advances (Deadline: 25 March 2025)
- Pharmacogenomics for Precision Medicine (Deadline: 25 March 2025)
- Drug Treatment of Cholangiocarcinoma (Deadline: 25 March 2025)
- Psychedelics: A New Drug Candidate for Treating Mental Illness (Deadline: 25 March 2025)
- Pharmacological Approaches of Chronic Obstructive Pulmonary Disease (COPD) and Lung Cancer (Deadline: 25 March 2025)
- Pharmacology and Mechanism of Action of Peptides in the Brain (Deadline: 25 March 2025)
- Novel Therapeutic Targets and Strategies for Drug Addiction (Deadline: 30 March 2025)
- Fluoroquinolones (Deadline: 31 March 2025)
- Pharmacovigilance in Drug Therapy: Drug–Drug Interactions and Safety Evaluation, 2nd Edition (Deadline: 31 March 2025)
- Drug Discovery, Development, and Synthesis for Glioblastoma (Deadline: 31 March 2025)
- Membrane Transporters in Drug Development: Recent Advances (Deadline: 5 April 2025)
- Pharmacotherapy for Alzheimer’s Disease (Deadline: 5 April 2025)
- New Insights of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Biomedical Applications (Deadline: 15 April 2025)
- Pharmacotherapy for Neuropathic Pain (Deadline: 20 April 2025)
- Drug Candidates for Allergic Diseases (Deadline: 25 April 2025)
- Oncolytic Viruses: New Cancer Immunotherapy Drugs (Deadline: 25 April 2025)
- Pharmacology and Toxicology of Opioids (Deadline: 25 April 2025)
- Discovery of Novel Antidepressants and Anxiolytics (Deadline: 25 April 2025)
- Ion Channels as Pharmacological Targets in Cancer (Deadline: 25 April 2025)
- Therapeutic Drug Monitoring and Adverse Drug Reactions: 2nd Edition (Deadline: 25 April 2025)
- New Development in Pharmacotherapy of Kidney Diseases (Deadline: 25 April 2025)
- Challenges and Emerging Trends in Photopharmacology (Deadline: 25 April 2025)
- New and Emerging Treatment Strategies for Gastrointestinal Diseases (Deadline: 30 April 2025)
- Pharmacology of Heart Failure (Deadline: 23 May 2025)
- Potential Therapeutic Targets for the Treatment of Pathological Pain (Deadline: 25 May 2025)
- NeuroImmunoEndocrinology (Deadline: 25 May 2025)
- The Pharmacology of Bisphosphonates: New Advances (Deadline: 25 May 2025)
- New Findings in Pharmacogenomics of Neuropsychiatric Disorders (Deadline: 25 May 2025)
- Cancer Pain—From Novel Mechanisms to Clinical Management (Deadline: 25 May 2025)
- Novel Therapeutic Strategies for Alzheimer’s Disease Treatment (Deadline: 25 May 2025)
- Discovery and Validation of Novel Antimicrobial Molecules for the Treatment of Multidrug-Resistant Bacterial Infections (Deadline: 30 May 2025)
- Pharmacotherapy of Endometriosis (Deadline: 31 May 2025)
- Drug Candidate for the Treatment of Glioblastoma (Deadline: 5 June 2025)
- Novel Strategies in Gangliosidoses Therapy (Deadline: 22 June 2025)
- New Advances in Antiarrhythmic Drugs (Deadline: 25 June 2025)
- Pharmacoepidemiology and Pharmacovigilance in Drug Therapy: New Issues, Challenges, and Applications (Deadline: 25 June 2025)
- Pharmaceuticals for Inflammatory Bowel Disease (IBD) (Deadline: 25 June 2025)
- Pediatric Drug Therapy: Safety, Efficacy, and Personalized Medicine (Deadline: 25 June 2025)
- Exploring Biomarkers and Pharmacotherapies for Substance Use Disorders (Deadline: 27 June 2025)
- Mesenchymal Stromal/Stem Cell-Based Drug Delivery Strategies: Translating Innovation from Bench to Bedside (Deadline: 30 June 2025)
- Pharmacotherapy of Diseases Affecting Urinary Tract (Deadline: 30 June 2025)
- Neuroblastoma Pathogenesis and Therapy (Deadline: 20 July 2025)
- Recent Advances in Cancer Diagnosis and Therapy (Deadline: 30 July 2025)
- Pharmacological Advances for Treatment in Hypertension 2.0 (Deadline: 31 July 2025)
- The Application of Pharmacogenetics in Toxicity Prevention and Drug Effect Improvement (Deadline: 31 July 2025)
- Advances in Pharmacotherapy for Nasal Disorders in Rhinology (Deadline: 30 September 2025)
Topical Collections
Following topical collections within this section are currently open for submissions:
